Nanna Therapeutics Overview

  • Founded
  • 2012
  • Status
  • Acquired/​Merged
  • Employees
  • 15
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $85.6M
Latest Deal Amount

Nanna Therapeutics General Information


Operator of a drug discovery company intended to provide new and transformative medicines for age-related diseases. The company's unique, game-changing platform accelerates drug discovery by its ability to create millions of novel compounds, functionally screen them at the nanoscale in multiple assays, including those with drug-like properties and toxicity, enabling drug discovery and development scientists with a set of proprietary technologies that radically disrupt current methods of creating new medicines.

Contact Information

Formerly Known As
Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Parent Company
Primary Office
  • The Merrifield Centre
  • Rosemary Lane
  • Cambridge CB1 3LQ
  • England, United Kingdom
+44 01223 000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanna Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 21-Apr-2020 $85.6M 00000 000.00 Completed Generating Revenue
2. Grant 09-Apr-2019 00.000 00000 Completed Generating Revenue
1. Early Stage VC 01-Dec-2014 $739K $739K 00.000 Completed Generating Revenue
To view Nanna Therapeutics’s complete valuation and funding history, request access »

Nanna Therapeutics Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
To view Nanna Therapeutics’s complete cap table history, request access »

Nanna Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
David Williams Ph.D Co-Founder, Chief Executive Officer & Board Member
Ernesto Reggiani Board Member & Chief Financial Officer
Alex Alanine Ph.D Chief Operating Officer
Stuart Wood Ph.D Chief Technology Officer
Nicki Thompson Ph.D Chief Business Officer & Chairman
You’re viewing 5 of 6 executive team members. Get the full list »

Nanna Therapeutics Board Members (6)

Name Representing Role Since
David Williams Ph.D Nanna Therapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
Ernesto Reggiani Nanna Therapeutics Board Member & Chief Financial Officer 000 0000
John Wain Ph.D Self Board Member 000 0000
Nicki Thompson Ph.D Nanna Therapeutics Chief Business Officer & Chairman 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Nanna Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanna Therapeutics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovate UK Government 000 0000 000000 0
New Wave Ventures Venture Capital Minority 000 0000 000000 0
To view Nanna Therapeutics’s complete investors history, request access »